COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES MEDIATED BY TLR4, IL1R, COX1/2 AND/OR RBP4

Patent number:

EP22382696

No items found.

The present invention refers to the medical field. Particularly, the present invention refers to a composition for use in the prevention and/or treatment of diseases mediated by TLR4, IL1R, COX1/2 and/or RBP4, preferably inflammatory diseases such as, for example, Osteoarthritis (OA) or other diseases, such as infectious diseases, causing an inflammatory response.

Countries:

Spain

Regions:

Galicia

Centers:

SERVIZO GALEGO DE SAUDE, INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA, OTHER

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

Currently there is no drug that blocks the TLR4 receptor and its associated responses, so this technology represents a disruptive change in the management of innate immunity and in the control of metabolic alterations dependent on the activation of TLR4 and IL1R receptors, the RBP4 protein, as well as the COX1/2 enzymes.

Comments

Other related patents

Health

IN VITRO METHOD FOR THE DIAGNOSIS AND/OR PROGNOSIS OF MALIGNANT MELANOMA

Countries

Spain

Health

Method for blood glucose control and artificial pancreas system for performing said method

Countries

Spain

Health

APPARATUS, METHOD AND SYSTEM FOR THE AMBULATORY RECORDING AND ANALYSIS OF INTRACRANIAL PRESSURE AS WELL AS FOR THE AUTOMATIC DETECTION OF ASSOCIATED PATHOLOGIES

Countries

Spain

Get back to patents directory